Evidence map›Paper›PMID 34996496›Full record

ArticleCritical care (London, England)2022

Impact of exposure time in awake prone positioning on clinical outcomes of patients with COVID-19-related acute respiratory failure treated with high-flow nasal oxygen: a multicenter cohort study.

Mariano Esperatti, Marina Busico, Nora Angélica Fuentes, Adrian Gallardo, Javier Osatnik, Alejandra Vitali, Elizabeth Gisele Wasinger, Matías Olmos, Jorgelina Quintana, Santiago Nicolas Saavedra and 14 more

Abstract readMulticenter Study
In one paragraph

Article in Critical care (London, England), 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 27 papers, 6 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
27citing papers in PubMed, 6 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

27 citing papers in PubMed, 6 syntheses or guidelines pooled it.

  1. Guideline
  2. Pooled it
  3. Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Review
  12. Article
  13. Article
  14. Observational
  15. Article
  16. Review
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Mariano EsperattiIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Marina BusicoIntensive Care Unit, Clínica Olivos SMG, Av. Maipú 1660, B1602 ABQ, Olivos, Provincia de Buenos Aires, Argentina. marinabusico@gmail.com.
Nora Angélica FuentesIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Adrian GallardoIntensive Care Unit, Sanatorio Clínica Modelo de Morón, Morón, Buenos Aires, Argentina.
Javier OsatnikIntensive Care Unit, Hospital Aleman, Ciudad Autónoma de Buenos Aires, Argentina.
Alejandra VitaliIntensive Care Unit, Sanatorio de La Trinidad Palermo, Ciudad Autónoma de Buenos Aires, Argentina.
Elizabeth Gisele WasingerIntensive Care Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina.
Matías OlmosIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Jorgelina QuintanaIntensive Care Unit, Clínica Olivos SMG, Av. Maipú 1660, B1602 ABQ, Olivos, Provincia de Buenos Aires, Argentina.
Santiago Nicolas SaavedraIntensive Care Unit, Hospital Aleman, Ciudad Autónoma de Buenos Aires, Argentina.
Ana Inés LagazioIntensive Care Unit, Sanatorio de La Trinidad Palermo, Ciudad Autónoma de Buenos Aires, Argentina.
Facundo Juan AndradaIntensive Care Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina.
Hiromi KakisuIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Nahuel Esteban RomanoIntensive Care Unit, Clínica Olivos SMG, Av. Maipú 1660, B1602 ABQ, Olivos, Provincia de Buenos Aires, Argentina.
Agustin MatarreseIntensive Care Unit, Hospital Aleman, Ciudad Autónoma de Buenos Aires, Argentina.
Mariela Adriana MogadouroIntensive Care Unit, Sanatorio de La Trinidad Palermo, Ciudad Autónoma de Buenos Aires, Argentina.
Giuliana MastIntensive Care Unit, Hospital Universitario Austral, Pilar, Buenos Aires, Argentina.
Claudia Navarro MorenoIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Greta Dennise Rebaza NiquinIntensive Care Unit, Hospital Aleman, Ciudad Autónoma de Buenos Aires, Argentina.
Veronica BarbaresiIntensive Care Unit, Hospital Privado de Comunidad, Mar del Plata, Argentina.
Alejandro Bruhn CruzDepartement of Intensive Medicine, Pontificia Universidad Católica de Chile, Santiago, Chile.
Bruno Leonel FerreyroInterdepartmental Division of Critical Care Medicine, University of Toronto, Toronto, Canada.
Antoni TorresPulmonary Department, Hospital Clinic, Universitat de Barcelona, IDIBAPS, CIBERES, Barcelona, Spain.
Argentine Collaborative Group on High Flow and Prone Positioning

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn patients with COVID-19-related acute respiratory failure (ARF), awake prone positioning (AW-PP) reduces the need for intubation in patients treated with high-flow nasal oxygen (HFNO). However, the effects of different exposure times on clinical outcomes remain unclear. We evaluated the effect of AW-PP on the risk of endotracheal intubation and in-hospital mortality in patients with COVID-19-related ARF treated with HFNO and analyzed the effects of different exposure times to AW-PP.

methodsThis multicenter prospective cohort study in six ICUs of 6 centers in Argentine consecutively included patients > 18 years of age with confirmed COVID-19-related ARF requiring HFNO from June 2020 to January 2021. In the primary analysis, the main exposure was awake prone positioning for at least 6 h/day, compared to non-prone positioning (NON-PP). In the sensitivity analysis, exposure was based on the number of hours receiving AW-PP. Inverse probability weighting-propensity score (IPW-PS) was used to adjust the conditional probability of treatment assignment. The primary outcome was endotracheal intubation (ETI); and the secondary outcome was hospital mortality.

resultsDuring the study period, 580 patients were screened and 335 were included; 187 (56%) tolerated AW-PP for [median (p25-75)] 12 (9-16) h/day and 148 (44%) served as controls. The IPW-propensity analysis showed standardized differences < 0.1 in all the variables assessed. After adjusting for other confounders, the OR (95% CI) for ETI in the AW-PP group was 0.36 (0.2-0.7), with a progressive reduction in OR as the exposure to AW-PP increased. The adjusted OR (95% CI) for hospital mortality in the AW-PP group ≥ 6 h/day was 0.47 (0.19-1.31). The exposure to prone positioning ≥ 8 h/d resulted in a further reduction in OR [0.37 (0.17-0.8)].

conclusionIn the study population, AW-PP for ≥ 6 h/day reduced the risk of endotracheal intubation, and exposure ≥ 8 h/d reduced the risk of hospital mortality.

Indexed as

COVID-19Oxygen Inhalation TherapyRespiratory InsufficiencyAdministration, IntranasalHumansOxygenProne PositionProspective StudiesTime FactorsTreatment OutcomeWakefulnessOxygenAcute respiratory failureAwakeCOVID-19Endotracheal intubationMortalityProne position

Identifiers

PMID34996496
PMCPMC8740872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.